Juan Jose Soler-Cataluna
Overview
Explore the profile of Juan Jose Soler-Cataluna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
2160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Padilla J, Alfaro E, Casitas R, Galera R, Martinez-Ceron E, Diaz-Garcia E, et al.
Arch Bronconeumol
. 2025 Feb;
PMID: 39971666
Backcround: Chronic obstructive pulmonary disease (COPD) is characterized by high morbidity and mortality, with physical inactivity being a major contributor to poor outcomes. This study aims to identify subgroups of...
2.
Loeb E, Zock J, Miravitlles M, Rodriguez E, Kromhout H, Vermeulen R, et al.
Toxics
. 2024 Oct;
12(10).
PMID: 39453109
Self-reported occupational exposure was previously associated with COPD in the Spanish population. This study aimed to analyse the relationship between occupational exposure to various chemical and biological agents, COPD, emphysema,...
3.
Bernabeu-Mora R, Valera-Novella E, Bernabeu-Serrano E, Soler-Cataluna J, Calle-Rubio M, Medina-Mirapeix F
Arch Bronconeumol
. 2024 Sep;
61(2):90-95.
PMID: 39245610
Objective: To determine if adding performance on the five-repetition sit-to-stand test (5-STS) to chronic obstructive pulmonary disease (COPD) high-risk criteria, proposed by the Spanish COPD guidelines (GesEPOC), affects mortality prognosis....
4.
Agusti A, Lopez-Campos J, Miravitlles M, Soler-Cataluna J, Marin J, Cosio B, et al.
Arch Bronconeumol
. 2024 May;
60(7):417-422.
PMID: 38729884
Introduction: Treatment with LABA/LAMA is recommended in GOLD B patients. We hypothesized that triple therapy (LABA/LAMA/ICS) will be superior to LABA/LAMA in achieving and maintaining clinical control (CC), a composite...
5.
de Miguel-Diez J, Villota J, Santos Perez S, Manito Lorite N, Navarrete B, Delgado Jimenez J, et al.
Arch Bronconeumol
. 2024 Feb;
60(4):226-237.
PMID: 38383272
Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently coexist, increasing the prevalence of both entities and impacting on symptoms and prognosis. CVD should be suspected in patients with...
6.
Loeb E, Zock J, Miravitlles M, Rodriguez E, Soler-Cataluna J, Soriano J, et al.
Arch Bronconeumol
. 2024 Jan;
60(1):16-22.
PMID: 38176851
Introduction: The aim of this study was to analyze the impact of occupational exposure on chronic obstructive pulmonary disease (COPD) and respiratory symptoms in the general Spanish population. Methods: This...
7.
Almagro P, Soler-Cataluna J, Huerta A, Gonzalez-Segura D, Cosio B
BMC Pulm Med
. 2024 Jan;
24(1):6.
PMID: 38166965
Background: Chronic obstructive pulmonary disease (COPD) frequently coexists with other chronic diseases, namely comorbidities. They negatively impact prognosis, exacerbations and quality of life in COPD patients. However, no studies have...
8.
Rey-Brandariz J, Perez-Rios M, Ahluwalia J, Beheshtian K, Fernandez-Villar A, Represas-Represas C, et al.
Arch Bronconeumol
. 2023 Jul;
59(11):717-724.
PMID: 37500327
Introduction: There is still uncertainty about which aspects of cigarette smoking influence the risk of Chronic Obstructive Pulmonary Disease (COPD). The aim of this study was to estimate the COPD...
9.
Martinez Deltoro A, Gamboa Martinez J, Soler-Cataluna J
Open Respir Arch
. 2023 Jul;
5(1):100214.
PMID: 37497254
Introduction: The benefits of CPAP in patients with obstructive sleep apnea (OSA) are not achieved without therapeutic adherence (TA). The perception of benefit is one of the main predictors of...
10.
Soler-Cataluna J, Martinez-Garcia M
Open Respir Arch
. 2023 Jul;
5(1):100234.
PMID: 37497248
Classically, the role of pulmonary infection in patients with chronic obstructive pulmonary disease (COPD) has focused on periods of exacerbation. However, in a clinically stable situation, little attention has been...